International Journal Of Hematologic Oncology impact factor, indexing, ranking (2024)

Aim and Scope

The International Journal Of Hematologic Oncology is a research journal that publishes research in the field of lymphoma, leukaemia, haematologic oncology, myeloma. This journal is published by the Future Medicine Ltd. The ISSN of this journal is 2045-1393.

Also, please check the following important details about international journal of hematologic oncology: Publisher, ISSN, Ranking, Indexing, Impact Factor (if applicable), Publication fee (APC), Review Time, and Acceptance Rate.

According to Clarivate's JCR, journals indexed in SCIE/SSCI have an impact factor.

The ISSN (International Standard Serial Number) is an 8-digit code used to uniquely identify journals. ISSN numbers are assigned by a network of ISSN National Centres, usually located at national libraries and coordinated by the ISSN International Centre based in Paris. The International Centre is an intergovernmental organization created in 1974 through an agreement between UNESCO and the French government.

Important Metrics

Journal Title:	International Journal of Hematologic Oncology
Publisher:	Future Medicine Ltd
P-ISSN:	2045-1393
E-ISSN:	2045-1407
Language:	English
Country of Publisher:	United Kingdom
APC:	Yes
Processing Time (Weeks):	13
Review Process:	Double anonymous peer review
Subjects:	Medicine: Internal medicine: Specialties of internal medicine: Diseases of the blood and blood-forming organs \| Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens

international journal of hematologic oncology Indexing

The international journal of hematologic oncology is indexed in:

DOAJ
PubMed

An indexed journal means that the journal has gone through and passed a review process of certain requirements done by a journal indexer.

The Web of Science Core Collection includes the Science Citation Index Expanded (SCIE), Social Sciences Citation Index (SSCI), Arts & Humanities Citation Index (AHCI), and Emerging Sources Citation Index (ESCI).

Publication fee

According to journal website, the publication fee of international journal of hematologic oncology is around 1415 USD.

The international journal of hematologic oncology has also Journal waiver policy (for developing countries, authors etc).

An article processing charge (APC), also known as a publication fee, is a fee which is sometimes charged to authors. Most commonly, it is involved in making a work available as open access (OA), in either a full OA journal or in a hybrid journal.

Call for Papers

Visit to the official website of the journal/ conference to check the details about call for papers.

How to publish in International Journal Of Hematologic Oncology?

If your research is related to lymphoma, leukaemia, haematologic oncology, myeloma, then visit the official website of international journal of hematologic oncology and send your manuscript.

Tips for publishing in International Journal Of Hematologic Oncology:

Selection of research problem.
Presenting a solution.
Designing the paper.
Make your manuscript publication worthy.
Write an effective results section.
Mind your references.

Acceptance Rate

Acceptance rate is the ratio of the number of articles submitted to the number of articles published. Researchers can check the acceptance rate on the journal website. Alternatively, they can contact the editor of the journal.

Journal Publication Time

The Journal Publication Time means the average number of weeks between article submission and publication. According to the journal website, the international journal of hematologic oncology publishes research articles in 13 weeks on an average.

Final Summary

It is published by Future Medicine Ltd.
The journal is indexed in , DOAJ, PubMed.
It is an open access journal.
The publication time (Average number of weeks between article submission and publication) of the journal is 13 weeks.
The Publication fee (APC) of international journal of hematologic oncology 1415 USD.